(Q43268514)

17 November 2017

title

Should a biopsy be recommended to confirm metastatic disease in women with breast cancer? (English)

1 reference

17 November 2017

1

1 reference

17 November 2017

2

Mark Clemons

1 reference

17 November 2017

publication date

1 October 2009

1 reference

Lancet Oncology Commission

17 November 2017

published in

1 reference

17 November 2017

volume

10

1 reference

17 November 2017

issue

10

1 reference

17 November 2017

page(s)

933-935

1 reference

The variability of estrogen receptors in metastatic breast cancer

17 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970295-5

7 January 2021

Estrogen and progesterone receptor concordance between primary and recurrent breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970295-5

7 January 2021

Change of HER-2/neu status in a subset of distant metastases from breast carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970295-5

7 January 2021

Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970295-5

7 January 2021

Biopsy confirmation of metastatic breast cancer: interim results of a prospective biopsy study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970295-5

7 January 2021

Discordance between receptor status in primary and metastatic breast cancer: an exploratory study of bone and bone marrow biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970295-5

7 January 2021

Reliance on hormone receptor assays of surgical specimens may compromise outcome in patients with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970295-5

7 January 2021

Technical pitfalls potentially affecting diagnoses in immunohistochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970295-5

7 January 2021

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970295-5

7 January 2021

Consensus recommendations on estrogen receptor testing in breast cancer by immunohistochemistry

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970295-5

7 January 2021

Quantitative imaging of estrogen receptor expression in breast cancer with PET and 18F-fluoroestradiol

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970295-5

7 January 2021

PET-based estradiol challenge as a predictive biomarker of response to endocrine therapy in women with estrogen-receptor-positive breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970295-5

7 January 2021

Development and characterization of clinical-grade 89Zr-trastuzumab for HER2/neu immunoPET imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970295-5

7 January 2021

Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970295-5

7 January 2021

10.1016/S1470-2045(09)70295-5

Identifiers

DOI

1 reference

17 November 2017

1 reference